Evidence map›Paper›PMID 39955474›Full record

ArticleMikrochimica acta2025

Luminescence "on-off-on" sensing of acute myocardial infarction biomarker miRNA-208a based on copper nanoclusters-MoS

Suzhen Zhang, Danling Mei, Hongming Fang, Quanwei Li, Xiumei Zhou, Xueqin Zhao, Zhencang Zheng, Biao Huang

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Suzhen ZhangCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
Danling MeiCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
Hongming FangXiaoshan Hospital, Hangzhou Normal University, Hangzhou, 311200, China.
Quanwei LiBeijing Institute of Hepatology, You'an Hospital, Capital Medical University, Beijing, 100069, China.
Xiumei ZhouCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
Xueqin ZhaoCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China. zhaoxueqin@zstu.edu.cn.
Zhencang ZhengDepartment of Critical Care Medicine, Taizhou Central Hospital, Taizhou University Hospital, Taizhou, 318000, Zhejiang, China. zhengzc2023@163.com.
Biao HuangCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China. huangbiao@zstu.edu.cn.

Funding

"Pioneer" and "Leading Goose" R&D Program of Zhejiang 2022C03118, 2023C03075the China Students' Innovation and Entrepreneurship Training Program 202410338044the Fundamental Research Funds of Zhejiang Sci-Tech University 24042127-Ythe Natural Science Foundation of Zhejiang Province LQ23H050005
6 · The paper itself

Abstract

MiRNA-208a is a molecular marker for the early stage of acute myocardial infarction (AMI), with satisfactory specificity and a relatively short time window, making it highly suitable for the early diagnosis of AMI. In this study, a CuNCs-cDNA-MoS

Indexed as

Biosensing TechniquesDisulfidesFluorescence Resonance Energy TransferMetal NanoparticlesMicroRNAsMyocardial InfarctionBiomarkersCopperFluorescent DyesHumansLimit of DetectionMolybdenumBiomarkersCopperDisulfidesFluorescent DyesMicroRNAsMIRN208 microRNA, humanMolybdenummolybdenum disulfideAcute myocardial infarctionCuNCsFluorescence sensorFRETMiRNA-208a

Identifiers

PMID39955474

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.